Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Journal of Experimental Botany
|
June 26, 2025
LATERAL BRANCHING OXIDOREDUCTASE specificity for strigolactone branching inhibition in barley
Maiko Inoue, Apriadi Situmorang, Jack H Kelly, et al.
Human Molecular Genetics
|
February 8, 2017
Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population
Yukihide Momozawa, Masato Akiyama, Yoichiro Kamatani, et al.
Journal of Human Genetics
|
July 29, 2018
Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degeneration
Masato Akiyama, Atsushi Takahashi, Yukihide Momozawa, et al.
Journal of Clinical Immunology
|
February 2, 2021
Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases
Akira Nishimura, Yuki Aoki, Yasuyoshi Ishiwata, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Journal of Experimental Botany
|
June 26, 2025
LATERAL BRANCHING OXIDOREDUCTASE specificity for strigolactone branching inhibition in barley
Maiko Inoue, Apriadi Situmorang, Jack H Kelly, et al.
Human Molecular Genetics
|
February 8, 2017
Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population
Yukihide Momozawa, Masato Akiyama, Yoichiro Kamatani, et al.
Journal of Human Genetics
|
July 29, 2018
Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degeneration
Masato Akiyama, Atsushi Takahashi, Yukihide Momozawa, et al.
Journal of Clinical Immunology
|
February 2, 2021
Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases
Akira Nishimura, Yuki Aoki, Yasuyoshi Ishiwata, et al.
Page
of 7